Refractive Transepithelial Photo-keratectomy (T-PKR) in High Myopia
Launched by CENTRE HOSPITALIER RÉGIONAL METZ-THIONVILLE · Jun 1, 2021
Trial Information
Current as of August 15, 2025
Completed
Keywords
ClinConnect Summary
In this retrospective study, 69 high myopic eyes of 6 diopters or more were treated in 38 patients by Trans-PRK with the SCHWIND Amaris 500E® excimer laser platform without the use of mitomycin-C. Several outcomes are measured in treated patients, such as postoperative uncorrected visual acuity (UCVA), best spectacle corrected visual acuity (BSCVA), efficacy, safety and predictability of the procedure, as well as corneal haze measurement. The patients are followed-up for 3 months.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age ≥18 years,
- • myopic sphere of -6 diopters or more,
- • astigmatism less than 3 diopters,
- • stable myopia not progressing for more than one year
- Exclusion Criteria:
- • age \<18 years,
- • myopic sphere less than -6 diopters,
- • astigmatism greater than 3 diopters,
- • progressive myopia (variation of more than 0.5 diopters over one year),
- • abnormal corneal topography or the presence of manifest keratoconus,
- • pre-existing eye pathology,
- • history of eye surgery,
- • active inflammatory or infectious eye disease,
- • dermatological disease or systemic connectivitis
About Centre Hospitalier Régional Metz Thionville
The Centre Hospitalier Régional Metz-Thionville is a leading healthcare institution in the Grand Est region of France, dedicated to delivering high-quality medical care and advancing clinical research. With a multidisciplinary team of experienced healthcare professionals, the center emphasizes patient-centered services and innovative treatment approaches. Committed to enhancing medical knowledge and improving patient outcomes, the hospital actively participates in clinical trials across various therapeutic areas, fostering collaboration with academic institutions and industry partners to drive advancements in healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Metz, , France
Patients applied
Trial Officials
Jean Marc PERONE, MD
Principal Investigator
CHR Metz Thionville Hopital de Mercy
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials